A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780

Trial Identifier:	D7960C00007
Sponsor:	AstraZeneca
Start Date:	August 2024
Primary Completion Date:	January 2025
Study Completion Date:	January 2025
Condition:	Heart, Blood & Circulatory - Other; Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.